| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.09 | 0.04 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.076 | 0.07 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.07 | 0.2 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.046 | 0.3 |